Rhesus monocyte-derived dendritic cells modified to over-express TGF-β1 exhibit potent veto activity

Clement Asiedu, Sai S. Dong, Alexander Pereboev, Weila Wang, Jesus Navarro, David T. Curiel, Judith M. Thomas

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Background. The tolerogenic activity of allogeneic bone marrow cells (BMCs) associates with functional inactivation of alloreactive T cells and has been attributed to a veto effect. Studies in mice and rhesus monkeys indicated that the CD8α molecule expressed on a subpopulation of allogeneic BMCs is necessary to induce signal transduction within the BMCs to increase veto effector molecules such as transforming growth factor (TGF)-β1. In vitro activation of alloreactive cytotoxic T-lymphocyte precursor enhances their susceptibility to veto-mediated functional inactivation by specific alloantigen-bearing BMCs. Accordingly, we examined a hypothesis that mature rhesus monkey (Rh) monocyte-derived dendritic cells (MDDCs) modified by gene transfer to over-express active TGF-β1 might mediate veto activity without the need to express CD8α. Methods. Rh MDDCs were modified by recombinant adenovirus (Ad) transduction and characterized by phenotype and functional studies. Results. Rh MDDC transduction with Ad vectors using conventional methods was remarkably inefficient. However, a single-chain anti-CD40/soluble Coxsackie and adenovirus receptor-fusion protein (G28/sCAR) permitted high-efficiency transduction of Rh MDDCs by retargeting Ad to Rh MDDC CD40. Mature Rh MDDCs that were transduced to overexpress active TGF-β1 (AdTGF-β1 Rh MDDC) significantly suppressed alloimmune responses in [3H]thymidine uptake mixed leukocyte reaction assays. We showed by the carboxyfluorescein succinimidyl ester dilution method that allogeneic mature AdTGF-β1 Rh MDDCs inhibited proliferation of CD4+ and CD8+ responder T cells. Notably, AdTGF-β1 Rh MDDC abrogated alloimmune responses induced by control AdGFP Rh MDDC in an antigen-specific manner. Conclusions. These results suggest that nonhuman primate mature MDDCs can be genetically engineered to function as alloantigen-specific cellular immunosuppressants, an approach that has potential to facilitate induction of allograft tolerance in vivo.

Original languageEnglish
Pages (from-to)629-637
Number of pages9
JournalTransplantation
Volume74
Issue number5
DOIs
StatePublished - Sep 15 2002

Fingerprint

Dive into the research topics of 'Rhesus monocyte-derived dendritic cells modified to over-express TGF-β1 exhibit potent veto activity'. Together they form a unique fingerprint.

Cite this